[Surgical treatment of late metastases of kidney cancer]
- PMID: 12434447
[Surgical treatment of late metastases of kidney cancer]
Abstract
Whereas 25-57% of patients diagnosed with renal cell carcinoma (RCC) present with metastatic disease, about 50% of (RCC) patients develop metastases after potentially curative radical nephrectomy. Five-year survival at following surgical removal of solitary metastases is approximately 35-50%. Our experience demonstrate that a small cohort of patients benefit from aggressive surgical therapy for consequtively arising solitary distant metastases with long-term palliation.
Publication types
MeSH terms
LinkOut - more resources
Medical